Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mostafa Ronaghi

Premium

BaseHealth said this week that Mostafa Ronaghi has joined its board of directors.

Currently, Ronaghi is Illumina's chief technology officer and senior vice president. Before joining Illumina, he founded several life sciences companies including ParAllele BioScience — which was acquired by Affymetrix — as well as Avantome and NextBio both of which were acquired by Illumina. He also previously spent nine years as a principal investigator at the Stanford Genome Technology Center. He is one of the inventors of pyrosequencing technology and a co-founder of Pyrosequencing AB (which was renamed Biotage).

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.